Clinical trials
Phase 3 Coronary Artery Disease trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 2 |
| Suspended | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| CSL Behring | 1 |
| Cogentus Pharmaceuticals | 1 |
| Eli Lilly and Company | 1 |
| Janssen Research & Development, LLC | 1 |
| NYU Langone Health | 1 |
| Novartis Pharmaceuticals | 1 |
| Resverlogix Corp | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 10 |
| Myocardial Infarction | 4 |
| Acute Coronary Syndrome | 3 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Heart Failure | 3 |
| Stroke | 3 |
| Atherosclerosis | 2 |
| Cerebrovascular Disorders | 2 |
| Heart Diseases | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.